Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection August 14, 2023https://classic.clinicaltrials.gov/ct2/show/NCT05010577
FDA Grants BiomX’s BX004 Clinical Program in Cystic Fibrosis Fast Track Designation August 9, 2023https://www.globenewswire.com/news-release/2023/08/09/2721423/0/en/BiomX-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html
